DHR Health Institute for Research and Development Recognized as a “Top Performing Site” Once Again

Translate to Spanish or other 102 languages!

THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
- Advertisement -

EDINBURG, Texas – The DHR Health Institute for Research and Development is delighted to announce that it has once again been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This marks the third consecutive time the Institute has received this prestigious distinction.

This recognition highlights the ongoing excellence and impact of the Research Institute as it continues to advance cancer research and improve patient outcomes.

“We are deeply honored and this recognition would not be possible without the assistance of the DHR Health Oncology Institute and the leadership of Dr. Jose Cruz,” said Dr. Scott Lillibridge, executive vice president for the DHR Health Institute for Research and Development.

- Advertisement -

SWOG is a global cancer research community supported by the National Cancer Institute (NCI), and recognition as a “Top Performing Site” signifies exceptional performance in clinical trial enrollment, data quality, and patient care standards.

The DHR Health Institute for Research and Development remains committed to innovation and delivering high-quality research opportunities to all residents of the Rio Grande Valley. They are located at 5323 S. McColl Road in Edinburg. For more information about clinical trials in the areas of liver, obesity, cancer, neurology, oncology and urology, call the Institute at (956) 362-2390.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New $2.5 Million Funding Boosts Stroke Care Access

Governor Greg Abbott announced $2.5 million in grant funding for hospitals to increase access to lifesaving stroke care through mobile stroke units.

DHR Health Encourages Community to Recognize the Signs of Stroke

The DHR Health Neuroscience Institute is urging the community to learn vital stroke prevention and response strategies. According to the Centers for Disease Control and Prevention (CDC), stroke remains a leading cause of death and disability worldwide.

TMA’s Prescription for Texas Lawmakers

To curb rising health care costs, physicians say Texas must reduce administrative waste, preserve meaningful coverage, and scrutinize market structures that reward consolidation and higher-cost settings.

Willie Underwood III, MD, Inaugurated as 181st AMA President

Willie Underwood III, M.D., MSc, M.P.H., a urologic surgeon based in Buffalo, N.Y., was sworn in today as the 181st president of the American Medical Association (AMA), the nation’s largest and most influential physician organization.
- Advertisement -